Delivery Order SPE2DB20D3101-SPE2DB24FRRF0

Award Date 7/30/24
Potential Completion Date 7/31/24
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,209.28, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Imiquimod 3.75% Cream 28S, a pharmaceutical product. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running through November 2026. The IDC serves as a primary...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $1,109.32, is for the delivery of Imiquimod 5% Cream Packets and has an ultimate completion date of May 21, 2024. This award is a Delivery Order under an Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Imiquimod 5% cream, a prescription medication, with a ceiling value of $3,713.31 and a period of performance through April 9, 2024. The contract is a Firm Fixed Price Delivery Order, without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a larger...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,406.36 Firm Fixed Price delivery order is for the supply of IMIQUIMOD 5% CREAM PACKET 12S, a pharmaceutical product. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical. This IDC serves as a primary vehicle for...
This federal contract award, valued at $6,103.36, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of IMIQUIMOD 5% CREAM PACKET 24S, a medical product, with a completion date of June 22, 2023. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,739.47 Firm Fixed Price Delivery Order covers the procurement of IMIQUIMOD 5% CREAM PACKET 12S, a pharmaceutical product, with a period of performance through November 18, 2024. The award is not associated with a set-aside program. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Imiquimod 5% Cream Packets. The order has a ceiling value of $10,479.63 and is a firm fixed-price contract. The contract has an ultimate completion date of August 14, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded multiple federal contracts and indefinite delivery contracts (IDCs) by the DLA and other agencies to provide a wide range of medical...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $22,833.98 firm fixed-price contract is for the delivery of IMIQUIMOD 3.75% CREAM 28S, a prescription medication. The award is not set aside for any specific business type, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also does...
This federal contract award, valued at $12,951.63, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp for the delivery of Imiquimod 5% Cream in 24-count packages. The contract is a Firm Fixed Price Delivery Order that runs through January 22, 2025. AmerisourceBergen is a major pharmaceutical distributor and healthcare solutions provider that holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Imiquimod 5% cream packets. The $2,309.30 contract has an ultimate completion date of April 8, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor and holds an indefinite delivery contract (IDC) with DLA valued at up to $999,999,999.00 through December 31, 2025 to...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB24FRRF0
    Delivery Order

This federal contract award is a delivery order issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of Imiquimod 3.75% cream, a topical medication, valued at $1,443.24. The award has an ultimate completion date of July 31, 2024 and is a firm fixed-price contract. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating it was awarded through open competition.

Generated 2/27/25, 11:00 AM